Viewing Study NCT06914895


Ignite Creation Date: 2025-12-24 @ 2:10 PM
Ignite Modification Date: 2025-12-27 @ 9:23 PM
Study NCT ID: NCT06914895
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-04-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module